295 related articles for article (PubMed ID: 22352740)
21. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
22. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.
Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ
Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039
[TBL] [Abstract][Full Text] [Related]
23. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
24. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
Zimmerman EI; Hu S; Roberts JL; Gibson AA; Orwick SJ; Li L; Sparreboom A; Baker SD
Clin Cancer Res; 2013 Mar; 19(6):1458-66. PubMed ID: 23340295
[TBL] [Abstract][Full Text] [Related]
25. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.
Mahagita C; Grassl SM; Piyachaturawat P; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G271-8. PubMed ID: 17412826
[TBL] [Abstract][Full Text] [Related]
26. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
[TBL] [Abstract][Full Text] [Related]
27. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
Smith NF; Figg WD; Sparreboom A
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
Schwarz UI; Meyer zu Schwabedissen HE; Tirona RG; Suzuki A; Leake BF; Mokrab Y; Mizuguchi K; Ho RH; Kim RB
Pharmacogenet Genomics; 2011 Mar; 21(3):103-14. PubMed ID: 21278621
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method.
Chan GH; Houle R; Zhang J; Katwaru R; Li Y; Chu X
Drug Metab Dispos; 2023 Sep; 51(9):1089-1104. PubMed ID: 37137718
[TBL] [Abstract][Full Text] [Related]
31. Rapid isolation of peptidic inhibitors of the solute carrier family transporters OATP1B1 and OATP1B3 by cell-based phage display selections.
Arita Y; Allen S; Chen G; Zhang W; Wang Y; Owen AJ; Dentinger P; Sidhu SS
Biochem Biophys Res Commun; 2016 Apr; 473(2):370-6. PubMed ID: 26792727
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
33. Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.
Boivin AA; Cardinal H; Barama A; Pichette V; Hébert MJ; Roger M
Drug Metab Pharmacokinet; 2010; 25(5):508-15. PubMed ID: 20877131
[TBL] [Abstract][Full Text] [Related]
34. Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters.
Kounnis V; Chondrogiannis G; Mantzaris MD; Tzakos AG; Fokas D; Papanikolaou NA; Galani V; Sainis I; Briasoulis E
Anticancer Res; 2015 Nov; 35(11):5857-65. PubMed ID: 26504008
[TBL] [Abstract][Full Text] [Related]
35. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
Zhang Y; Ruggiero M; Hagenbuch B
Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
[TBL] [Abstract][Full Text] [Related]
36. Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.
Herfindal L; Krakstad C; Myhren L; Hagland H; Kopperud R; Teigen K; Schwede F; Kleppe R; Døskeland SO
PLoS One; 2014; 9(4):e94926. PubMed ID: 24740327
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
38. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Karlgren M; Vildhede A; Norinder U; Wisniewski JR; Kimoto E; Lai Y; Haglund U; Artursson P
J Med Chem; 2012 May; 55(10):4740-63. PubMed ID: 22541068
[TBL] [Abstract][Full Text] [Related]
39. Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells.
Monks NR; Liu S; Xu Y; Yu H; Bendelow AS; Moscow JA
Mol Cancer Ther; 2007 Feb; 6(2):587-98. PubMed ID: 17308056
[TBL] [Abstract][Full Text] [Related]
40. Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO members.
Gui C; Hagenbuch B
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Apr; 151(3):393-9. PubMed ID: 20079461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
